Lying face-down could improve breathing in severe coronavirus cases, studies suggest
Throughout the coronavirus pandemic, doctors have reported success in treating patients who were having trouble breathing by shifting them into prone — or face-down — position. Two recent small studies appear to back up their intuitions.
One study published by JAMA Internal Medicine last week found that out of 25 non-intubated COVID-19 patients with severe respiratory symptoms in New York City who spent at least one waking hour in prone position, 19 saw their oxygen saturation improve to 95 percent or greater, which lowered the risk of more invasive ventilation methods.
A similar study published in The Lancet last week monitored 56 patients with COVID-19-related pneumonia in Manza, Italy, 47 of whom were able to be repositioned. Researchers found that prone positioning was "feasible and effective in ameliorating blood oxygenation in awake patients." Upon returning to a supine, or face-up position, 23 of those patients maintained their improved breathing. The study didn't find a significant difference in the rate of intubation between those who responded to prone positioning and those who didn't.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Both studies were small and acknowledge the hypothesis warrants further examination, including randomized trials, but coupled with the anecdotal success doctors have reported, the researchers suggest repositioning could be a simple, safe, and useful mitigation method. Read the results of the studies at The Lancet and JAMA Internal Medicine.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published